News

Thymosin Alpha-1 Clinical Trials: How to Design...

Learn how to design a rigorous thymosin alpha-1 clinical trial, covering patient selection, dosing, endpoints, blinding, statistics, and regulatory

Statistical Power Analysis in Thymosin Alpha-1 ...

Statistical power analysis determines sample sizes for Thymosin Alpha-1 trials. Learn how effect sizes and endpoints shape immune restoration study

Protocoles de contrôle par placebo dans les ess...

Analyse des défis méthodologiques des essais contrôlés par placebo sur la thymosine alpha-1 : insu, choix du placebo, critères de jugement et leçons

Blinding and Placebo Controls in GHRP-6 Trials

Blinding and placebo controls shape the validity of GHRP-6 trials. Subjective appetite endpoints are prone to unblinding bias. Objective GH endpoints are